HTR2A gene variation is involved in antidepressant treatment response
Lucae, Susanne, Ising, Marcus, Horstmann, Sonja, Baune, Bernhard T., Arolt, Volker, Muller-Myhsok, Bertram, Holsboer, Florian, and Domschke, Katharina (2010) HTR2A gene variation is involved in antidepressant treatment response. European Neuropsychopharmacology, 20 (1). pp. 65-68.
PDF (Published Version)
Restricted to Repository staff only
Two serotonin 2A receptor (HTR2A) SNPs recently reported to be associated with antidepressant treatment response in STAR*D (rs7997012; rs1928040) were analyzed for association with treatment response in two independent Caucasian samples of patients with a Major Depressive Episode. In the combined sample (n=637) SNP rs7997012 was significantly associated with remission after five weeks providing first replicative support for the initial finding, with, however, an inverse allelic association as compared to the STAR*D sample.
|Item Type:||Article (Refereed Research - C1)|
|Keywords:||HTR2A; pharmacogenetics; SNP; treatment response; major depression; association study|
|Date Deposited:||07 Feb 2010 23:53|
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1109 Neurosciences > 110999 Neurosciences not elsewhere classified @ 100%|
|SEO Codes:||92 HEALTH > 9204 Public Health (excl. Specific Population Health) > 920410 Mental Health @ 100%|
|Citation Count from Web of Science||